Jump to Navigation
Home

Main menu

  • Home
  • News
  • Markets Map
  • Sentiments
  • Topics
  • Data
  • Comments
  • Images
  • Blog
  • About

Secondary menu

  • Latest News
  • Top Rated
  • Most Popular
  • Archive
  • Discussions
  • Best Buy profit tops estimates, sales miss
  • All eyes on Toronto city hall as Mayor Rob Ford expected...
  • J.C. Penney Is A Basket Case
  • Double trouble for Bundesliga?
  • The cartoonist that scares Syria's Assad
  • 7 Afghan police officers killed in blast
  • Dambisa Moyo: Search For Alpha Leads To Frontier Markets...
  • Why Flanigan's Enterprises' Shares Are...
  • JPMorgan on Edge Over Jamie Dimon Vote
  • Corrections: U.K. stocks extend gains to 12-year high

    Why We Think The S&P 500 Has Valuation Upside

    Thu, 05/17/2012 - 07:14 EDT - Seeking Alpha
    • SPY
    • Valuentum

    By Valuentum:
    At Valuentum, we think the best exchange traded funds are those that have a low or reasonable expense ratio, have holdings that are collectively underpriced, and have technical and momentum indicators that are currently exhibiting bullish trends.We embrace forward-looking thinking, and our ETF ratings consider the forward-looking fair values of an ETF's holdings, using our robust equity valuation process and the Valuentum Buying Index as a guide. Other research firms may not even calculate a fair value estimate for an ETF's holdings, leaving us to wonder how they can possibly form an opinion on the future direction of an ETF's fundamental value. And surprisingly, the ratings of other well-known independent ETF research providers aren't even used to select their favorite funds. So what are investors to do?Well, we believe the future is all that matters in investing, and comparing and ranking the historical performance of an ETF versusComplete Story »

    • Original article
    • Login or register to post comments
     

    Related

    • Analyzing Apple's Valuation: Expecting Further Upside

      By Valuentum: As part of our process, we perform a rigorous discounted cash-flow methodology that dives into the true intrinsic worth of companies. In Apple's (AAPL) case, we think the firm is worth north of $500 per share. Our full reports on Apple and hundreds of other companies are available on our website.

    • Libbey Still Has Valuation Upside

      By Valuentum: As part of our process, we perform a rigorous discounted cash-flow methodology that dives into the true intrinsic worth of companies. In Libbey's (LBY) case, we think the firm is undervalued. We think it is fairly valued at $23 per share, still representing material upside to where it is currently trading.

    • Why Deere Has Valuation Upside Beyond $90 Per Share

      By Valuentum: As part of our process, we perform a rigorous discounted cash-flow methodology that dives into the true intrinsic worth of companies. In Deere's (DE) case, we think the firm is fairly valued at $93, just above where it is currently trading.

    • Not Much Upside Left In FedEx's Shares

      By Valuentum: As part of our process, we perform a rigorous discounted cash-flow methodology that dives into the true intrinsic worth of companies. In FedEx's (FDX) case, we think the firm is fairly valued at $83 per share, which is slightly lower than where it is currently trading.

    • Boeing's Upside Not As Great As Its Suppliers'

      By Valuentum: As part of our process, we perform a rigorous discounted cash-flow methodology that dives into the true intrinsic worth of companies. In Boeing's (BA) case, we think the firm is fairly valued at $77 per share, which is slightly higher than where it is currently trading.

    • Visa Has Meaningful Valuation Upside

      By Valuentum: As part of our process, we perform a rigorous discounted cash-flow methodology that dives into the true intrinsic worth of companies. In Visa's (V) case, we think the firm is worth over $125 per share, significantly higher than where it is currently trading.

    • Kraft Offers Investors Significant Upside

      By Valuentum: As part of our process, we perform a rigorous discounted cash-flow methodology that dives into the true intrinsic worth of companies. In Kraft's (KFT) case, we think the firm is currently worth just shy of $50 per share, significantly higher than where it is currently trading.

    • Exxon Shares May Be Fairly Valued, But Its Dividend Payout Has Substantial Upside

      By Valuentum: As part of our process, we use a rigorous discounted cash-flow methodology that uncovers the true intrinsic value of companies. In Exxon Mobil's (XOM) case, we think the firm is worth about $80 per share.

    • Abbott Labs Has More Than 30% Upside

      By Valuentum: As part of our stock-research process, we use a rigorous discounted cash-flow process that uncovers the true intrinsic worth of companies. After updating our valuation assumptions for Abbott, we think the firm is worth just under $70 per share, up from about $63 previously.

    • Corrective phase of U.S. equities not over, according to technical indicators

      Article written by Prieur du Plessis, editor of the Investment Postcards from Cape Town blog.“A number of technical indicators have been very helpful in timing the end of prior corrective phases when cyclical equity conditions were still generally constructive, i.e. a sustainable, low inflation global economic expansion and the absence of significantly overvalued conditions,” BCA Research said yesterday. “Currently, these indicators suggest that the corrective action in the broad U.S.

    Latest

    MOBILE INSIGHTS: The Mobile Payment Wars Heat Up Again
    MOBILE INSIGHTS: The Mobile Payment Wars Heat Up...
    Home Depot Crushes Earnings On US Housing Market Recovery (HD)
    Home Depot Crushes Earnings On US Housing Market...

    User login

    • Create new account
    • Request new password
    • Click on the icon to sign in with your social network login or enter your Bullfax.com login

    Our Blog

    • Marks & Spenser, Bank Loans in China, Vodafone and Asian Stocks in Our News for Today 05/21/2013
    • Actavis to acquire Warner Chilcott in $5bn pharmaceutical deal
    • Quantative Easing: Not on the long run

    Markets Map

    Markets Map

    Follow Us

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS
    S&P 500: 1666.29 -0.07% FTSE: 6767.03 0.17% Nikk.: 15381.02 0.13% DAX: 8433.19 -0.27% HSI: 23366.369 -0.54% FX: EUR/GBP: 1.1766 USD/EUR: 1.287 JPY/USD: 102.805 Commodities: Gold: 1375.35

    Bullfax.com - Market News & Analysis 2008-2011
    Contact Us | About Us | Terms & Conditions

    Follow Us on Facebook, Twitter, Google Plus and RSS LinkedIn Facebook Twitter Google Plus RSS .

    Secondary menu

    • Latest News
    • Top Rated
    • Most Popular
    • Archive
    • Discussions